^
    CANCER:

    Breast Cancer





    Show legend
    Group by Gene:
    Include preclinical:

    HER2 inhibitor
    trastuzumab
    margetuximab
    tucatinib
    LZM-005
    Zercepac (trastuzumab biosimilar)
    trastuzumab + LZM-005
    trastuzumab-dttb
    trastuzumab-dkst
    trastuzumab-anns
    trastuzumab + tucatinib
    trastuzumab-qyyp
    trastuzumab-pkrb
    TX05 (trastuzumab biosimilar)
    Hervelous (trastuzumab biosimilar)
    		0
    HER2 inhibitor
    ZW25
    KN026
    DF1001
    EG12014 (trastuzumab biosimilar)
    trastuzumab / hyaluronidase-oysk
    HERtiCAD (trastuzumab biosimilar)
    ZN-A-1041
    DZD1516
    inetetamab
    MP0274
    Hercease (trastuzumab biosimilar)
    VRN101099
    AB-201
    trastuzumab
    trastuzumab-IFN-β mutein
    CDK4 inhibitor + CDK6 inhibitor
    ribociclib
    abemaciclib
    palbociclib
    trilaciclib
    XZP 3287
    dalpiciclib
    		1
    CDK4 inhibitor, CDK6 inhibitor
    G1T38
    palbociclib + ribociclib
    TQB3616
    FCN-437
    BPI-16350
    palbociclib + abemaciclib
    PRT3645
    CS3002
    PARP inhibitor
    olaparib
    talazoparib
    niraparib
    		2
    PARP inhibitor
    ABT-888
    pamiparib
    fluzoparib
    IMP4297
    NOV 1401
    rucaparib
    alpelisib
    GDC-0032
    CYH33
    		3
    PIK3CA inhibitor
    GDC-0077
    alpelisib + GDC-0032
    HS-10352
    LX-086
    RLY-2608
    tamoxifen
    		4
    Estrogen receptor antagonist
    tamoxifen
    tamoxifen
    bevacizumab
    Aybintio (bevacizumab biosimilar)
    Krabeva (bevacizumab biosimilar)
    		5
    VEGF-A inhibitor
    bevacizumab-maly
    bevacizumab-adcd
    bevacizumab-bvzr
    bevacizumab-awwb
    Selective estrogen receptor degrader
    fulvestrant
    elacestrant
    SAR439859
    AZD9833
    G1T48
    		6
    Selective estrogen receptor degrader
    GDC-0927
    D-0502
    ZN-c5
    SCR-6852
    LY3484356
    LX-039
    AZD9496
    SCR6106
    Aromatase inhibitor
    exemestane
    		7
    Aromatase inhibitor
    anastrozole
    letrozole
    Aromatase inhibitor
    pegylated liposomal doxorubicin
    doxorubicin hydrochloride
    non-pegylated liposomal doxorubicin
    		8
    Topoisomerase II inhibitor
    epirubicin
    pegylated liposomal doxorubicin
    doxorubicin hydrochloride
    etoposide IV
    PD1 inhibitor
    pembrolizumab
    nivolumab
    		9
    PD1 inhibitor
    toripalimab-tpzi
    tislelizumab
    cemiplimab-rwlc
    nivolumab + toripalimab-tpzi
    dostarlimab-gxly
    atezolizumab
    		10
    PD-L1 inhibitor
    durvalumab
    avelumab
    capecitabine
    		11
    Thymidylate synthase inhibitor
    gimeracil / oteracil / tegafur
    tegafur / uracil
    5-fluorouracil
    gemcitabine
    		12
    DNA synthesis inhibitor
    cisplatin
    nedaplatin
    13
    mTOR inhibitor
    everolimus
    AZD8055
    14
    Tubulin polymerization promoter
    carboplatin
    15
    Tubulin polymerization inhibitor
    vinorelbine tartrate
    vincristine
    trastuzumab + pertuzumab
    pertuzumab + trastuzumab-pkrb
    		16
    HER2 inhibitor, HER2 dimerization inhibitor
    pertuzumab + trastuzumab-dttb
    pertuzumab + Zercepac (trastuzumab biosimilar)
    pertuzumab + inetetamab
    pertuzumab / trastuzumab / hyaluronidase-zzxf
    toremifene
    		17
    Selective estrogen receptor modulator
    lasofoxifene
    afimoxifene
    18
    Bcl2 inhibitor, Tubulin inhibitor
    albumin-bound paclitaxel
    paclitaxel oral
    capivasertib
    		19
    AKT inhibitor
    TAS-117
    MK-2206
    GSK690693
    FGFR inhibitor
    futibatinib
    infigratinib
    		20
    FGFR inhibitor
    ABSK091
    Debio 1347
    ARQ 087
    E7090
    ixabepilone
    		21
    Microtubule inhibitor
    E7389-LF
    cabazitaxel
    22
    RNA polymerase 1 inhibitor
    CX-5461
    trastuzumab + abemaciclib
    trastuzumab + palbociclib
    		23
    HER2 inhibitor, CDK4 inhibitor, CDK6 inhibitor
    palbociclib + tucatinib
    palbociclib + ZW25
    tucatinib + PRT3645
    abemaciclib + tucatinib
    24
    Bone resorption factor inhibitor, Osteoclast inhibitor
    zoledronic acid
    25
    GnRH agonist
    leuprolide acetate for depot suspension
    triptorelin
    26
    Mitosis inhibitor
    vinorelbine
    27
    Progesterone receptor agonist
    megestrol
    28
    Tubulin polymerization promoter, Bcl2 inhibitor
    paclitaxel
    carboplatin + paclitaxel
    29
    PI3K inhibitor, AKT inhibitor
    RG7440
    anlotinib
    pazopanib
    ponatinib
    		30
    Multi-tyrosine kinase inhibitor
    TT-00420
    vandetanib
    cabozantinib capsule
    midostaurin
    31
    PD-L1 inhibitor, PARP inhibitor
    avelumab + talazoparib
    olaparib + durvalumab
    tamoxifen + fulvestrant
    		32
    Estrogen receptor antagonist, Selective estrogen receptor degrader
    GDC-9545
    OP-1250
    pembrolizumab + niraparib
    		33
    PD1 inhibitor, PARP inhibitor
    tislelizumab + pamiparib
    pembrolizumab + olaparib
    PI3K inhibitor
    AN2025
    		34
    PI3K inhibitor
    GDC-0941
    MEN1611
    SB02024
    35
    PARG inhibitor
    IDE161
    CT7001
    		36
    CDK7 inhibitor
    SY-5609
    Q901
    YPN-005
    37
    TrkB receptor inhibitor, TrkC kinase inhibitor, TrkA receptor inhibitor
    larotrectinib
    38
    mTORC1 inhibitor, mTORC2 inhibitor
    CB-228
    39
    VEGFR-2 inhibitor, PARP inhibitor
    rivoceranib + fluzoparib
    40
    Androgen receptor inhibitor
    enzalutamide capsule
    darolutamide
    41
    HER2 dimerization inhibitor
    QL1209 (pertuzumab biosimilar)
    pertuzumab
    42
    Selective estrogen receptor α inhibitor
    H3B-6545
    43
    Bcl2 inhibitor
    venetoclax
    44
    Ubiquitin pathway modulator, Estrogen receptor alpha degrader
    ARV-471
    45
    RANK ligand inhibitor
    denosumab
    46
    Immunostimulant, G-CSF stimulant
    SV-BR-1-GM
    47
    VEGFR-2 inhibitor
    rivoceranib
    fulvestrant + anastrozole
    		48
    Aromatase inhibitor, Selective estrogen receptor degrader
    fulvestrant + letrozole
    letrozole + SAR439859
    49
    HER2 inhibitor, mTOR inhibitor
    trastuzumab + everolimus
    sirolimus + inetetamab
    50
    HER2 inhibitor, HER4 inhibitor, pan-EGFR inhibitor
    poziotinib
    51
    CXCR4 antagonist
    POL 6326
    52
    FGFR inhibitor, VEGFR inhibitor, PDGFR inhibitor, pan-TRK inhibitor
    TKI258
    53
    HER2-targeted antibody-drug conjugate, DNA replication inhibitor
    trastuzumab duocarmazine
    54
    Aurora kinase A inhibitor
    MLN8237
    55
    PI3Kγ inhibitor
    IPI-549
    CZC24832
    56
    IGF-1R inhibitor
    AMG 479
    ASP7487
    57
    Alkylating agent, DNA synthesis inhibitor
    cisplatin + cyclophosphamide
    cyclophosphamide + thiotepa
    58
    eIF4A1 inhibitor, CDK4 inhibitor, CDK6 inhibitor
    abemaciclib + eFT226
    palbociclib + CR-1-31-B
    59
    PIK3CA inhibitor, HER2 inhibitor, HER2 dimerization inhibitor
    trastuzumab + pertuzumab + alpelisib
    60
    TTK inhibitor
    CFI-402257
    VRN08
    61
    Tubulin inhibitor, Thymidylate synthase inhibitor
    capecitabine + DJ 927
    62
    Alkylating agent
    D19466
    cyclophosphamide
    63
    HER2 inhibitor, HER3 inhibitor
    MCLA-128
    trastuzumab + MCLA-128
    crizotinib
    		64
    ALK inhibitor
    alectinib
    ceritinib
    cetuximab
    gefitinib
    		65
    EGFR inhibitor
    Hemay022
    WZ4002
    erlotinib
    CL-387785
    CDK2 inhibitor
    		66
    CDK2 inhibitor
    PF-07104091
    BLU-222
    67
    PD1 inhibitor, CTLA4 inhibitor
    nivolumab + ipilimumab
    68
    IL-6R antagonist
    tocilizumab
    69
    ATR inhibitor, PARP inhibitor
    olaparib + AZD6738
    ABT-888 + M6620
    70
    PD1 inhibitor, Multi-tyrosine kinase inhibitor
    camrelizumab + SHR 1020
    71
    HER2-targeted antibody-drug conjugate, Tubulin inhibitor
    A166
    72
    VEGF-A inhibitor, PD1 inhibitor
    nivolumab + bevacizumab
    73
    Microtubule inhibitor, Notch3-targeted antibody-drug conjugate
    PF-06650808
    74
    PD-L1 inhibitor, PARP inhibitor, AKT inhibitor
    olaparib + durvalumab + capivasertib
    75
    Proteasome inhibitor
    ixazomib
    bortezomib
    76
    PARP inhibitor, AKT inhibitor
    olaparib + capivasertib
    77
    DNA synthesis inhibitor, Bcl2 inhibitor, Tubulin inhibitor
    cisplatin + albumin-bound paclitaxel
    78
    VEGF-A inhibitor, HER2 inhibitor
    bevacizumab + trastuzumab
    79
    Tubulin polymerization promoter, Bcl2 inhibitor, Tubulin inhibitor
    carboplatin + albumin-bound paclitaxel
    80
    RET inhibitor
    pralsetinib
    selpercatinib
    romidepsin
    panobinostat
    		81
    HDAC inhibitor
    SB939
    vorinostat
    MGCD0103
    trastuzumab + lapatinib
    		82
    HER2 inhibitor, EGFR inhibitor
    lapatinib
    trastuzumab + S-222611
    mobocertinib
    83
    HER2 inhibitor, PD1 inhibitor
    pembrolizumab + trastuzumab
    camrelizumab + inetetamab
    84
    Progesterone receptor antagonist
    onapristone XR
    RAIN-32
    		85
    MDM2 inhibitor
    KRT-232 + APG-115
    CGM097
    86
    Tubulin polymerization promoter, DNA synthesis inhibitor
    carboplatin + gemcitabine
    87
    MEK inhibitor
    trametinib
    selumetinib
    88
    Microtubule inhibitor, LY6E-targeted antibody-drug conjugate
    DLYE5953A
    89
    ATR inhibitor
    BAY 1895344
    M6620
    90
    PIK3CA inhibitor, PARP inhibitor
    olaparib + alpelisib
    91
    PLK4 inhibitor
    CFI-400945
    92
    AXL inhibitor, HER2 inhibitor
    trastuzumab + TP-0903
    cyclophosphamide + non-pegylated liposomal doxorubicin
    		93
    Topoisomerase II inhibitor, Alkylating agent
    doxorubicin hydrochloride + cyclophosphamide
    cyclophosphamide + epirubicin
    94
    VEGFR inhibitor, PD-L1 inhibitor, PARP inhibitor
    olaparib + durvalumab + cediranib
    95
    Tubulin polymerization promoter, Alkylating agent, Bcl2 inhibitor
    carboplatin + paclitaxel + cyclophosphamide
    96
    pan-AKT inhibitor
    LAE002
    97
    PD-L1 inhibitor, CTLA4 inhibitor
    KN046
    98
    CEBPB antagonist
    ST101
    99
    Androgen receptor agonist
    CR 1477
    100
    Wnt signalling pathway inhibitor
    OMP-18R5
    101
    HDAC inhibitor, HDAC1 inhibitor, HDAC2 inhibitor, HDAC3 inhibitor
    entinostat
    102
    WEE1 inhibitor
    AZD1775
    ZN-c3
    103
    Selective estrogen receptor degrader, AKT inhibitor
    capivasertib + AZD9833
    104
    Topoisomerase I inhibitor
    DAN-222
    105
    PD1 inhibitor, MEK inhibitor
    pembrolizumab + binimetinib
    106
    HDAC6 inhibitor
    ACY-1215
    107
    VEGFR-2 inhibitor, HER2 inhibitor
    trastuzumab + rivoceranib
    108
    Tubulin polymerization inhibitor, Thymidylate synthase inhibitor
    capecitabine + vinorelbine tartrate
    109
    Topoisomerase II inhibitor, DNA inhibitor
    etoposide oral
    110
    KAT6 inhibitor
    PF-07248144
    ISM5043
    111
    Apoptosis stimulant
    pelareorep
    112
    Estrogen receptor antagonist, mTOR inhibitor
    everolimus + tamoxifen
    113
    PARP7 inhibitor
    RBN-2397
    114
    THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor
    methotrexate
    115
    Androgen receptor inhibitor, Selective estrogen receptor degrader
    enzalutamide capsule + fulvestrant
    116
    Estrogen receptor antagonist, mTORC1 inhibitor, mTORC2 inhibitor
    tamoxifen + CB-228
    117
    ERN1 inhibitor
    ORIN1001
    118
    Androgen receptor antagonist, TMPRSS2 inhibitor
    GT0918
    119
    MEK inhibitor, BRAF inhibitor
    trametinib + dabrafenib
    120
    CDK4 inhibitor, CDK6 inhibitor, Multi-tyrosine kinase inhibitor
    dalpiciclib + SHR 1020
    121
    PD-L1 inhibitor, VEGF-A inhibitor
    BNT327
    bevacizumab + atezolizumab
    122
    Notch inhibitor
    RG4733
    CB-103
    123
    DNA methylation inhibitor
    azacitidine
    TdCyd
    124
    VEGF-A inhibitor, mTOR inhibitor
    bevacizumab + temsirolimus
    125
    PD1 inhibitor, CDK inhibitor
    pembrolizumab + MK-7965
    126
    Alkylating agent, Thymidylate synthase inhibitor
    capecitabine + D19466
    127
    APC activator
    eftilagimod alpha
    128
    BRAF inhibitor, BRAF V600E inhibitor
    vemurafenib
    129
    Selective androgen receptor modulator
    EP0062
    130
    BET inhibitor, PARP inhibitor
    talazoparib + ZEN-3694
    131
    Thymidine phosphorylase inhibitor
    trifluridine / tipiracil
    132
    AKT inhibitor, p70S6K inhibitor
    LY2780301
    CCT128930
    133
    Tubulin inhibitor
    DJ 927
    134
    CCR5 receptor antagonist, Viral entry inhibitor
    leronlimab
    135
    CDK4 inhibitor
    PF-07220060
    136
    FASN inhibitor
    TVB-2640
    137
    PIK3CA inhibitor, HER2 inhibitor, HER3 inhibitor
    trastuzumab + alpelisib + LJM-716
    138
    PVRIG inhibitor, PD1 inhibitor
    nivolumab + COM701
    139
    PIK3CA inhibitor, Selective estrogen receptor degrader
    alpelisib + LY3484356
    140
    mTOR inhibitor, Selective estrogen receptor degrader
    everolimus + LY3484356
    141
    PIK3CA inhibitor, HER2 inhibitor
    trastuzumab + alpelisib
    142
    DNA replication inhibitor, AXL-targeted antibody-drug conjugate
    ADCT-601
    143
    Selective estrogen receptor covalent antagonist
    HRS8807
    144
    Microtubule inhibitor, CD166-targeted antibody-drug conjugate
    CX-2009
    145
    Topoisomerase II inhibitor, HER2-targeted antibody-drug conjugate
    MM-302
    146
    IAP inhibitor
    APG-1387
    IGM-9427
    FEC
    TAC
    Nab-PHP + PldCHP
    EC-TH
    CaT
    THP
    TC
    TCHP
    ECP-THP
    CMF
    TEC
    CAF
    TCbHP
    VEX
    		147
    Chemotherapy
    PH-FECH
    PCbTP
    VIP
    AC-THP
    EC-P
    TH
    GC
    EC
    AC
    GT
    ACT
    GemCarbo
    FAC
    AC-TH
    TCH
    148
    FAK inhibitor
    FAK inhibitor
    VS-4718
    149
    HER2-targeted CAR-T immunotherapy
    HER2-targeted CAR-T immunotherapy
    150
    Immunotherapy
    Immunotherapy
    151
    MUC1 inhibitor
    MUC1 inhibitor
    152
    HDAC inhibitor, AKT1 inhibitor
    HDAC inhibitor + AKT1 inhibitor
    153
    HDAC inhibitor, AKT2 inhibitor
    HDAC inhibitor + AKT2 inhibitor
    154
    CDK19 inhibitor
    CDK19 inhibitor
    155
    CDK8 inhibitor
    CDK8 inhibitor
    156
    EGFR-targeted antibody-drug conjugate
    EGFR-targeted antibody-drug conjugate
    157
    Tyrosine kinase inhibitor
    Tyrosine kinase inhibitor
    PD173074
    158
    Immunotherapy, PARP inhibitor
    Immunotherapy + PARP inhibitor
    159
    B7-H3-targeted antibody-drug conjugate
    B7-H3-targeted antibody-drug conjugate
    160
    PI3K inhibitor, mTOR inhibitor, AKT inhibitor
    mTOR inhibitor + PI3K inhibitor + AKT inhibitor
    DFN-529
    161
    Aurora kinase inhibitor, WEE1 inhibitor
    WEE1 inhibitor + Aurora kinase inhibitor
    162
    PD-L1 inhibitor, MYC inhibitor
    PD-L1 inhibitor + MYC inhibitor
    163
    HER2 inhibitor, Erythropoiesis stimulating agent
    HER2 inhibitor + Erythropoiesis stimulating agent
    164
    Aromatase inhibitor, HER2 inhibitor
    HER2 inhibitor + Aromatase inhibitor
    165
    mTORC1 inhibitor
    mTORC1 inhibitor
    166
    EZH2 inhibitor, PARP inhibitor
    PARP inhibitor + EZH2 inhibitor
    167
    CDK4 inhibitor, EGFR inhibitor, CDK6 inhibitor
    EGFR inhibitor + CDK4 inhibitor + CDK6 inhibitor
    erlotinib + palbociclib
    CDK4 inhibitor + CDK6 inhibitor + Aromatase inhibitor
    		168
    Aromatase inhibitor, CDK4 inhibitor, CDK6 inhibitor
    Aromatase inhibitor + palbociclib
    letrozole + dalpiciclib
    CDK4 inhibitor + CDK6 inhibitor + fulvestrant
    		169
    CDK4 inhibitor, CDK6 inhibitor, Selective estrogen receptor degrader
    palbociclib + SAR439859
    abemaciclib + AZD9833
    abemaciclib + LY3484356
    170
    PI3K inhibitor, Selective estrogen receptor degrader
    PI3K inhibitor + fulvestrant
    MEN1611 + elacestrant
    171
    Immunotherapy, Selective estrogen receptor degrader
    Immunotherapy + fulvestrant
    172
    β-catenin inhibitor, CBP inhibitor, Microtubule inhibitor
    eribulin mesylate
    173
    β-catenin inhibitor, CBP inhibitor, Microtubule inhibitor, Chemotherapy
    HP + eribulin mesylate
    174
    Aromatase inhibitor, Thymidylate synthase inhibitor
    Aromatase inhibitor + capecitabine
    175
    Aromatase inhibitor, HER2 inhibitor, EGFR inhibitor
    Aromatase inhibitor + trastuzumab + lapatinib
    176
    Tyrosine kinase inhibitor, Thymidylate synthase inhibitor
    Tyrosine kinase inhibitor + capecitabine
    177
    Aromatase inhibitor, HDAC inhibitor
    HDAC inhibitor + exemestane
    178
    Aromatase inhibitor, mTOR inhibitor
    exemestane + mTOR inhibitor
    everolimus + exemestane
    ado-trastuzumab emtansine
    disitamab vedotin
    DP303c
    JNJ-0683
    MRG002
    TAA013
    ZW49
    		179
    HER2-targeted antibody-drug conjugate, Microtubule inhibitor
    XMT-1522
    IKS014
    PF-06804103
    MEDI4276
    ALT-P7
    BAT8001
    BB-1701
    MF-TTZ-MMAE
    carboplatin + docetaxel
    		180
    Microtubule stabilizer, Tubulin polymerization promoter
    docetaxel
    docetaxel
    fam-trastuzumab deruxtecan-nxki
    SHR-A1811
    		181
    HER2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    BL-M07D1
    BNT323
    PRO1102
    DAN-311
    neratinib
    pyrotinib
    trastuzumab + neratinib
    		182
    HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
    afatinib
    trastuzumab + pyrotinib
    pyrotinib + inetetamab
    ASLAN001
    lapatinib + neratinib
    sacituzumab govitecan-hziy
    MK-2870
    		183
    TROP-2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    DS-1062a
    ESG401
    BL-M02D1
    BAT8008
    184
    Microtubule stabilizer, Tubulin polymerization promoter, Thymidylate synthase inhibitor
    docetaxel + capecitabine
    185
    Topoisomerase II inhibitor, Microtubule stabilizer, Tubulin polymerization promoter
    docetaxel + doxorubicin hydrochloride
    docetaxel + epirubicin
    186
    Topoisomerase II inhibitor, Microtubule stabilizer, Tubulin polymerization promoter, Alkylating agent
    docetaxel + doxorubicin hydrochloride + cyclophosphamide
    187
    HER2-targeted antibody-drug conjugate, Microtubule inhibitor, HER2 dimerization inhibitor
    pertuzumab + ado-trastuzumab emtansine
    188
    HER3-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    U3-1402
    DB-1310
    189
    CDK4 inhibitor, PI3K inhibitor, mTOR inhibitor, mTORC1 inhibitor, CDK6 inhibitor, mTORC2 inhibitor
    palbociclib + PF-05212384
    190
    HER2 inhibitor, PI3K inhibitor, mTOR inhibitor, mTORC1 inhibitor, mTORC2 inhibitor
    PF-05212384 + trastuzumab-pkrb
    191
    Microtubule stabilizer, Tubulin polymerization promoter, DNA synthesis inhibitor
    gemcitabine + docetaxel
    192
    Androgen receptor modulator, Selective androgen receptor modulator
    enobosarm
    193
    FGFR inhibitor, CDK4 inhibitor, CDK6 inhibitor
    palbociclib + BAY 1163877
    palbociclib + ABSK091
    194
    FGFR inhibitor, VEGFR inhibitor, RET inhibitor, c-KIT inhibitor, PDGFR α antagonist
    lenvatinib
    195
    VEGFR inhibitor, PDGFR inhibitor, c-KIT inhibitor
    sunitinib
    palbociclib + GDC-0032
    palbociclib + GDC-0077
    palbociclib + alpelisib
    		196
    PIK3CA inhibitor, CDK4 inhibitor, CDK6 inhibitor
    alpelisib + ribociclib
    alpelisib + abemaciclib
    abemaciclib + RLY-2608
    palbociclib + RLY-2608
    197
    Topoisomerase II inhibitor, Tubulin polymerization promoter, Alkylating agent, Bcl2 inhibitor
    paclitaxel + cyclophosphamide + epirubicin
    198
    TNKS inhibitor, PARP inhibitor
    JPI-547
    199
    PD-L1 inhibitor, Multi-tyrosine kinase inhibitor
    anlotinib + APL-502
    200
    TrkB receptor inhibitor, TrkC kinase inhibitor, ROS1 inhibitor, TrkA receptor inhibitor, ALK inhibitor, JAK2 inhibitor, TNK2 inhibitor
    entrectinib
    pyrotinib + dalpiciclib
    		201
    HER2 inhibitor, HER4 inhibitor, CDK4 inhibitor, EGFR inhibitor, CDK6 inhibitor
    trastuzumab + palbociclib + pyrotinib
    palbociclib + neratinib
    202
    FGFR inhibitor, VEGFR inhibitor, PDGFR α-β inhibitor, Tyrosine kinase inhibitor
    E 3810
    203
    PI3K inhibitor, mTOR inhibitor, mTORC1 inhibitor, mTORC2 inhibitor
    PF-05212384
    204
    B7-H4-targeted antibody-drug conjugate, Tubulin inhibitor
    XMT-1660
    205
    P-glycoprotein inhibitor, Bcl2 inhibitor, Tubulin inhibitor
    oral paclitaxel / encequidar
    206
    AKT3 inhibitor, AKT1 inhibitor, AKT inhibitor, p70S6K inhibitor
    DIACC3010
    207
    Topoisomerase II inhibitor, Alkylating agent, Bcl2 inhibitor, Tubulin inhibitor
    albumin-bound paclitaxel + cyclophosphamide + epirubicin
    208
    PI3K inhibitor, mTOR inhibitor, mTORC1 inhibitor, PARP inhibitor, mTORC2 inhibitor
    talazoparib + PF-05212384
    209
    Selective estrogen receptor modulator, Estrogen receptor antagonist
    Z-endoxifen hydrochloride
    210
    FGFR2 inhibitor, FGFR inhibitor, FGFR1 inhibitor, FGFR3 inhibitor, CDK4 inhibitor, FGFR4 inhibitor, CDK6 inhibitor
    palbociclib + erdafitinib
    211
    Topoisomerase II inhibitor, Tubulin polymerization inhibitor
    epirubicin + vinorelbine tartrate
    212
    HER2 inhibitor, HER4 inhibitor, HER2-targeted antibody-drug conjugate, EGFR inhibitor, Microtubule inhibitor
    neratinib + ado-trastuzumab emtansine
    ado-trastuzumab emtansine + pyrotinib
    213
    PD-L1 inhibitor, PI3K inhibitor, AKT inhibitor
    atezolizumab + RG7440
    214
    RNA polymerase inhibitor, Alkylating agent, Apoptosis stimulant
    lurbinectedin
    215
    Estrogen receptor antagonist, HER2 inhibitor, Selective estrogen receptor degrader
    HER2 inhibitor + OP-1250
    216
    Aromatase inhibitor, HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
    pyrotinib + letrozole
    217
    PD1 inhibitor, HER2-targeted antibody-drug conjugate, Microtubule inhibitor
    pembrolizumab + ado-trastuzumab emtansine
    disitamab vedotin + zimberelimab
    218
    DNA synthesis inhibitor, PARP inhibitor
    temozolomide + ABT-888
    219
    PD1 inhibitor, HER2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    nivolumab + fam-trastuzumab deruxtecan-nxki
    220
    TSP1 stimulant, CD36 stimulant
    VT1021
    221
    Ubiquitin pathway modulator, CDK4 inhibitor, CDK6 inhibitor, Estrogen receptor alpha degrader
    palbociclib + ARV-471
    222
    Estrogen receptor antagonist, CDK4 inhibitor, CDK6 inhibitor, Selective estrogen receptor degrader
    palbociclib + OP-1250
    223
    PARP inhibitor, Topoisomerase I inhibitor
    niraparib + DAN-222
    224
    β-catenin inhibitor, DNA synthesis inhibitor, CBP inhibitor, Microtubule inhibitor
    gemcitabine + eribulin mesylate
    225
    Microtubule stabilizer, Tubulin polymerization promoter, Alkylating agent
    docetaxel + cyclophosphamide
    226
    DDR enhancer, PARP inhibitor, Topoisomerase I inhibitor
    rucaparib + PLX038
    227
    PD-L1 inhibitor, HER2 inhibitor, HER2 dimerization inhibitor
    trastuzumab + atezolizumab + pertuzumab
    228
    Protein synthesis inhibitor, HER2 inhibitor
    MT-5111
    229
    Topoisomerase II inhibitor, HER2 inhibitor, HER2-targeted antibody-drug conjugate
    trastuzumab + MM-302
    230
    PD-L1 inhibitor, Immunostimulant
    atezolizumab + RG6180
    231
    Lyase inhibitor, Androgen receptor antagonist
    TAK 700
    paclitaxel + epirubicin
    		232
    Topoisomerase II inhibitor, Tubulin polymerization promoter, Bcl2 inhibitor
    carboplatin + paclitaxel + doxorubicin hydrochloride
    carboplatin + paclitaxel + non-pegylated liposomal doxorubicin
    paclitaxel + doxorubicin hydrochloride
    233
    CDK4 inhibitor, PI3K inhibitor, CDK6 inhibitor
    ribociclib + AN2025
    234
    HER2 inhibitor, JAK1 inhibitor, JAK2 inhibitor
    trastuzumab + ruxolitinib
    235
    HER2 inhibitor, HER2-targeted antibody-drug conjugate, Microtubule inhibitor
    ado-trastuzumab emtansine + tucatinib
    tucatinib + disitamab vedotin
    236
    Chk1 inhibitor, Chk2 inhibitor
    ACR-368
    AZD-7762
    237
    HDAC inhibitor, MAPK inhibitor, HDAC10 inhibitor, HDAC1 inhibitor, PI3K inhibitor, HDAC2 inhibitor, AKT inhibitor, HDAC3 inhibitor
    chidamide
    238
    VEGF-A inhibitor, Mitochondrial OXHPHOS inhibitor, mTOR inhibitor
    bevacizumab + ME-344
    239
    β-catenin inhibitor, Tubulin polymerization promoter, CBP inhibitor, Microtubule inhibitor
    carboplatin + eribulin mesylate
    palbociclib + everolimus
    		240
    CDK4 inhibitor, mTOR inhibitor, CDK6 inhibitor
    everolimus + ribociclib
    everolimus + abemaciclib
    241
    AKT3 inhibitor, HER2 inhibitor, AKT1 inhibitor, AKT inhibitor, p70S6K inhibitor
    trastuzumab + DIACC3010
    242
    HER2 inhibitor, CTLA4 inhibitor
    trastuzumab + tremelimumab
    243
    JAK1 inhibitor, JAK2 inhibitor
    ruxolitinib
    244
    DNA replication inhibitor, Thymidylate synthase inhibitor
    capecitabine + bendamustine
    245
    PD-L1 inhibitor, HER2 inhibitor, CTLA4 inhibitor
    KN046 + KN026
    246
    PIK3CA inhibitor, Estrogen receptor antagonist
    tamoxifen + GDC-0032
    PF-06873600
    		247
    CDK2 inhibitor, CDK4 inhibitor, CDK6 inhibitor
    palbociclib + BLU-222
    RGT-419B
    ribociclib + BLU-222
    248
    Androgen receptor antagonist, Selective estrogen receptor degrader, TMPRSS2 inhibitor
    fulvestrant + GT0918
    249
    BRAF inhibitor, MEK1 inhibitor, BRAF V600E inhibitor
    vemurafenib + cobimetinib
    250
    Topoisomerase II inhibitor, Alkylating agent, G-CSF stimulant, Bcl2 inhibitor, Tubulin inhibitor
    albumin-bound paclitaxel + cyclophosphamide + epirubicin + pegfilgrastim
    251
    Estrogen receptor antagonist, GnRH agonist
    tamoxifen + goserelin acetate
    252
    MDMX inhibitor, MDM2 inhibitor
    ALRN-6924
    253
    HER2 inhibitor, PD1 inhibitor, HER2 dimerization inhibitor
    pembrolizumab + pertuzumab + trastuzumab-qyyp
    254
    CDK4 inhibitor, Selective estrogen receptor α inhibitor, CDK6 inhibitor
    palbociclib + H3B-6545
    255
    HER2 inhibitor, HER2-targeted antibody-drug conjugate, Microtubule inhibitor, HER2 dimerization inhibitor
    trastuzumab + pertuzumab + ado-trastuzumab emtansine
    256
    HER2-targeted antibody-drug conjugate, Microtubule inhibitor, Topoisomerase I inhibitor
    ado-trastuzumab emtansine + fam-trastuzumab deruxtecan-nxki
    257
    PD-L1 inhibitor, HER2-targeted antibody-drug conjugate, Microtubule inhibitor
    atezolizumab + ado-trastuzumab emtansine
    258
    HER2 inhibitor, PD1 inhibitor, LAG-3 inhibitor
    margetuximab + MGD013
    259
    PD1 inhibitor, GM-CSF agonist, CTLA4 inhibitor
    nivolumab + ipilimumab + talimogene laherparepvec
    260
    PD-L1 inhibitor, PD1 inhibitor
    pembrolizumab + durvalumab
    261
    GPNMB-targeted antibody-drug conjugate, Microtubule inhibitor
    CDX-011
    262
    PD-L1 inhibitor, HER2 inhibitor
    trastuzumab + atezolizumab
    trastuzumab + durvalumab
    263
    CD137 agonist, HER2 inhibitor
    PRS-343
    264
    TLR9 agonist, PD1 inhibitor
    pembrolizumab + SD-101
    265
    β-catenin inhibitor, CBP inhibitor, PD1 inhibitor, Microtubule inhibitor
    pembrolizumab + eribulin mesylate
    266
    PI3K inhibitor, JAK2 inhibitor
    GDC-0941 + AZ 960
    267
    IGF-2 inhibitor, CDK4 inhibitor, IGF1 inhibitor, CDK6 inhibitor
    abemaciclib + BI-836845
    268
    HER2 inhibitor, PI3K inhibitor
    trastuzumab + MEN1611
    trastuzumab + SAR245408
    269
    THF dehydrogenase inhibitor, Alkylating agent, Dihydrofolic acid reductase inhibitor, Thymidylate synthase inhibitor
    capecitabine + cyclophosphamide + methotrexate
    270
    HER2 inhibitor, HER2-targeted antibody-drug conjugate, EGFR inhibitor, Microtubule inhibitor
    lapatinib + ado-trastuzumab emtansine
    271
    IGF-2 inhibitor, mTOR inhibitor, IGF1 inhibitor
    everolimus + BI-836845
    272
    β-catenin inhibitor, CBP inhibitor, Microtubule inhibitor, Thymidylate synthase inhibitor
    capecitabine + eribulin mesylate
    273
    Tubulin polymerization promoter, Apoptosis stimulant, Bcl2 inhibitor
    paclitaxel + pelareorep
    274
    DNA synthesis inhibitor, DNA cross linking agent, Apoptosis inhibitor, Microtubule inhibitor
    INT230-6
    275
    Bcr-abl tyrosine kinase inhibitor, CDK4 inhibitor, Src kinase inhibitor, CDK6 inhibitor
    palbociclib + bosutinib
    276
    HER2 inhibitor, CD20 inhibitor
    trastuzumab + TQB2303 (rituximab biosimilar)
    277
    PD-L1 inhibitor, HER2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    durvalumab + fam-trastuzumab deruxtecan-nxki
    278
    Aromatase inhibitor, mTOR inhibitor, GnRH agonist
    everolimus + letrozole + leuprolide acetate
    279
    PD-L1 inhibitor, GM-CSF agonist
    atezolizumab + talimogene laherparepvec
    280
    CDK4 inhibitor, PD1 inhibitor, CDK6 inhibitor
    pembrolizumab + palbociclib
    pembrolizumab + abemaciclib
    281
    PIK3CA inhibitor, HER2 inhibitor, PI3Kδ inhibitor
    trastuzumab + copanlisib
    282
    Microtubule stabilizer, Tubulin polymerization promoter, Sortilin inhibitor
    TH 1902
    283
    CDK4 inhibitor, HER2-targeted antibody-drug conjugate, CDK6 inhibitor, Microtubule inhibitor
    palbociclib + ado-trastuzumab emtansine
    284
    VEGF-A inhibitor, HER2-targeted antibody-drug conjugate, Microtubule inhibitor
    bevacizumab + disitamab vedotin
    285
    HER2-targeted antibody-drug conjugate, TROP-2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    fam-trastuzumab deruxtecan-nxki + sacituzumab govitecan-hziy
    286
    PIK3CA inhibitor, CDK4 inhibitor, CDK6 inhibitor, PI3Kδ inhibitor
    abemaciclib + copanlisib
    287
    CDK4 inhibitor, PI3K inhibitor, CDK6 inhibitor, AKT inhibitor
    palbociclib + RG7440
    288
    PIK3CA inhibitor, Estrogen receptor antagonist, Selective estrogen receptor degrader
    GDC-9545 + GDC-0077
    289
    HER2 inhibitor, CDK4 inhibitor, CDK6 inhibitor, HER2 dimerization inhibitor
    trastuzumab + palbociclib + pertuzumab
    290
    SIK3 inhibitor, PI3K inhibitor, PI3Kγ inhibitor, PI3Kδ inhibitor
    RP6530
    291
    EGFR inhibitor, MUC1 inhibitor
    gatipotuzumab + tomuzotuximab
    292
    PD-L1 inhibitor, CDK4 inhibitor, CDK6 inhibitor
    atezolizumab + abemaciclib
    293
    PTK7-targeted antibody-drug conjugate, TROP-2-targeted antibody-drug conjugate
    BCG033
    294
    HER2 inhibitor, CDK4 inhibitor, EGFR inhibitor, CDK6 inhibitor
    palbociclib + lapatinib
    295
    CDK4 inhibitor, CDK6 inhibitor, PARP inhibitor
    talazoparib + abemaciclib
    olaparib + palbociclib
    296
    p53 reactivator
    APR-246
    297
    PIK3CA inhibitor, HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
    alpelisib + pyrotinib
    298
    HER2 inhibitor, α radiation emission
    BAY2701439
    299
    PI3K inhibitor, mTOR inhibitor
    GDC-0980
    RTB101
    300
    PD1 inhibitor, PI3Kδ inhibitor
    camrelizumab + linperlisib
    301
    HER2-targeted antibody-drug conjugate, NMT inhibitor
    MYX2449
    302
    Microtubule inhibitor, EGFR-targeted antibody-drug conjugate
    LR004-VC-MMAE
    HTI-1511
    303
    MUC1-targeted antibody-drug conjugate, Microtubule inhibitor
    3D1-MMAE
    304
    MERTK-targeted antibody-drug conjugate, Microtubule inhibitor
    RGX-019-MMAE
    305
    Microtubule inhibitor, LIV-1-targeted antibody-drug conjugate
    BRY812
    SGN-LIV1A
    306
    Melanotransferrin modulator, HER2-targeted antibody-drug conjugate
    BT2111
    307
    Nectin-4-targeted antibody-drug conjugate, Microtubule inhibitor
    9MW2821
    308
    Microtubule inhibitor, TROP-2-targeted antibody-drug conjugate
    LCB84
    BAT8003
    309
    IGF-1R-targeted antibody-drug conjugate, Microtubule inhibitor
    W0101
    310
    HER2-targeted antibody-drug conjugate, HER3-targeted antibody-drug conjugate, GSPT1 degrader
    ORM-5029
    311
    Prolactin receptor-targeted antibody-drug conjugate, DNA cross linking agent
    ABBV-176
    312
    LAMP1-targeted antibody-drug conjugate, Microtubule inhibitor
    SAR428926
    313
    Globo H-targeted antibody-drug conjugate, Microtubule inhibitor
    OBI-999
    314
    DNA replication inhibitor, ROR1-targeted antibody-drug conjugate
    NBE-002
    315
    5T4-targeted antibody-drug conjugate, Microtubule inhibitor
    ASN004
    316
    PARP inhibitor, WEE1 inhibitor
    olaparib + AZD1775
    niraparib + AZD1775
    317
    B7-H3-targeted antibody-drug conjugate, DNA replication inhibitor
    ITC-6102RO
    MGC018
    STX-478
    		318
    PI3Kα H1047R mutation inhibitor
    OKI-219
    LOXO-783
    319
    MNK1 degrader, MNK2 degrader
    VNLG-152R
    320
    HER2 inhibitor, HER2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    fam-trastuzumab deruxtecan-nxki + tucatinib
    321
    CDK4 inhibitor, CDK6 inhibitor, CDK9 inhibitor
    palbociclib + AZD4573
    322
    ATM kinase inhibitor
    AZD1390
    323
    SIRPA inhibitor, STAT3 inhibitor, HER2-targeted antibody-drug conjugate, TNF inhibitor, Topoisomerase I inhibitor
    fam-trastuzumab deruxtecan-nxki + INB03
    324
    XPO1 inhibitor, Nuclear export inhibitor
    KPT-8602
    325
    PLK1 inhibitor
    PCM-075
    326
    CDK6 degrader, CDK4 degrader
    BTX-9341
    327
    CDK19 inhibitor, CDK8 inhibitor
    RVU120
    328
    PLK1 inhibitor, PIK3CA inhibitor
    alpelisib + PCM-075
    329
    PI3Kα H1047R mutation inhibitor, CDK4 inhibitor, CDK6 inhibitor
    palbociclib + STX-478
    330
    PI3Kα H1047R mutation inhibitor, Selective estrogen receptor degrader
    AZD9833 + OKI-219
    elacestrant + OKI-219
    331
    HER2 inhibitor, PI3Kα H1047R mutation inhibitor
    tucatinib + OKI-219
    332
    IDO inhibitor
    NLG8189
    333
    Angiopoietin 1 inhibitor, TIE-2 antagonist, Angiopoietin 2 inhibitor
    AMG 386
    334
    BET inhibitor
    JQ-1
    ZEN-3694
    335
    Ribonucleotide reductase inhibitor
    NSC-324360
    336
    NEDD8 activating enzyme inhibitor
    MLN4924
    337
    HER2-targeted antibody-drug conjugate, DNA replication inhibitor, PARP inhibitor
    olaparib + niraparib + trastuzumab duocarmazine
    338
    Microtubule inhibitor, CD228-targeted antibody-drug conjugate
    SGN-CD228A
    339
    pan-CLK inhibitor, DYRK inhib
    SM08502
    340
    Androgen receptor antagonist
    apalutamide
    HC-1119
    341
    CBP inhibitor, EP300 inhibitor
    FT-6876
    342
    CDK4 inhibitor, CDK6 inhibitor, PDK1 inhibitor
    palbociclib + VRx-510
    ribociclib + VRx-510
    343
    CDK4 inhibitor, CDK6 inhibitor, MDM2 inhibitor
    palbociclib + CGM097
    344
    Bcr-abl tyrosine kinase inhibitor, Src kinase inhibitor, c-KIT inhibitor, PDGFR β antagonist, EphA2 receptor antagonist
    dasatinib
    345
    Bcr-abl tyrosine kinase inhibitor, HER2 inhibitor, EGFR inhibitor, Src kinase inhibitor, c-KIT inhibitor, PDGFR β antagonist, EphA2 receptor antagonist
    dasatinib + lapatinib
    346
    HER2 inhibitor, HER4 inhibitor, HER2-targeted antibody-drug conjugate, EGFR inhibitor, Topoisomerase I inhibitor
    neratinib + fam-trastuzumab deruxtecan-nxki
    347
    DRD1 partial agonist
    levo-tetrahydropalmatine
    348
    Ferroptosis inducer
    erastin
    349
    NRF2 inhibitor
    brusatol
    trastuzumab + GS-4721
    		350
    HER2 inhibitor, CD47 inhibitor
    IMM2902
    D3L-001
    351
    Microtubule inhibitor, Bcl2 inhibitor, Bcl-xL inhibitor, Bcl-w inhibitor, EGFR-targeted antibody-drug conjugate
    ABT 263 + ABT-414
    352
    DNA replication inhibitor, Bcl2 inhibitor, Bcl-xL inhibitor, Bcl-w inhibitor, EGFR-targeted antibody-drug conjugate
    ABT 263 + ABBV-321
    353
    Aurora kinase inhibitor
    ENMD-2076
    354
    HER2 inhibitor, EGFR inhibitor, Multi-tyrosine kinase inhibitor
    AEE788
    355
    PI3Kβ inhibitor
    AZD8186
    356
    mTOR inhibitor, EGFR inhibitor
    gefitinib + everolimus
    357
    VEGFR inhibitor, PDGFR inhibitor, ALK inhibitor, c-KIT inhibitor
    crizotinib + sunitinib
    358
    mTOR inhibitor, mTORC1 inhibitor
    RapaLink-1
    359
    γ-secretase inhibitor
    nirogacestat
    360
    mTOR inhibitor, mTORC2 inhibitor
    PP242
    361
    pan-AKT inhibitor, CDK4 inhibitor, CDK6 inhibitor
    palbociclib + ARQ 751
    362
    JNK inhibitor
    JNK-IN-8
    363
    LIF inhibitor
    EC359
    364
    TrxR inhibitor, AKT inhibitor
    MK-2206 + D9
    365
    HER2 inhibitor, HER4 inhibitor, mTOR inhibitor, EGFR inhibitor
    everolimus + neratinib
    366
    HER2 inhibitor, HER4 inhibitor, MEK inhibitor, EGFR inhibitor
    trametinib + neratinib
    367
    pan-RAF inhibitor, Apoptosis inducer, PP2A activator, Multi-tyrosine kinase inhibitor
    sorafenib + nanoliposomal ceramide
    368
    MERTK-targeted antibody-drug conjugate
    RGX-019
    369
    SF3B1 inhibitor, RNA splicing modulator
    SSA
    370
    ER-α 36 modulator
    SNG-162
    371
    eIF4A1 inhibitor
    eFT226
    372
    BET inhibitor, CDK4 inhibitor, CDK6 inhibitor
    palbociclib + ZEN-3694
    abemaciclib + ZEN-3694
    373
    CDK4 inhibitor, CDK6 inhibitor, Bcl2 inhibitor
    palbociclib + APG-2575
    374
    p53 stimulant
    COTI-2
    375
    PP2A inhibitor
    LB-100
    376
    PD-L1 inhibitor, CD73 inhibitor
    durvalumab + MEDI9447
    377
    ERK2 inhibitor, PI3K inhibitor, ERK inhibitor, ERK1 inhibitor, GnRH agonist
    triptorelin + AEZS 136 + AEZS-134
    378
    PI3K inhibitor, ERK inhibitor, GnRH agonist
    triptorelin + AEZS-129
    379
    GnRH agonist, AKT inhibitor
    triptorelin + D21266
    380
    NQO1 inhibitor
    ARQ 761
    381
    THF dehydrogenase inhibitor, Thymidylate synthase inhibitor
    pemetrexed
    382
    Haspin inhibitor
    CHR-6494
    383
    β-catenin inhibitor, Tubulin polymerization promoter, CBP inhibitor, Microtubule inhibitor, Bcl2 inhibitor
    paclitaxel + eribulin mesylate
    384
    Chk1 inhibitor, WEE1 inhibitor
    AZD1775 + SRA737
    385
    PIK3CA inhibitor, CDK4 inhibitor, mTOR inhibitor, CDK6 inhibitor, Selective estrogen receptor degrader
    everolimus + alpelisib + abemaciclib + LY3484356
    386
    HER2 inhibitor, HER4 inhibitor, EGFR inhibitor, PARP inhibitor
    neratinib + niraparib
    olaparib + neratinib
    387
    PARP1 inhibitor
    AZD5305
    388
    T-cell stimulant, HER2 inhibitor, CD3 agonist, CD28 agonist
    SAR443216
    389
    ADAM9-targeted antibody-drug conjugate, Microtubule inhibitor
    IMGC936
    390
    EGFR inhibitor, CD16A agonist
    AFM24
    391
    Annexin A1 inhibitor
    MDX-124
    392
    PARP2 inhibitor, PARP1 inhibitor
    TQB3823
    393
    pan-RAF inhibitor, Multi-tyrosine kinase inhibitor
    sorafenib
    394
    AMPK activator
    metformin
    395
    HER3 inhibitor
    MM-121
    396
    β-catenin inhibitor, CBP inhibitor, Wnt signalling pathway inhibitor
    PRI724
    397
    XPO1 inhibitor
    selinexor
    398
    TGF-β RI kinase inhibitor, TGF-β R2 kinase inhibitor
    LY2109761
    399
    DNA synthesis inhibitor, DNA cross linking agent
    oxaliplatin
    400
    ERK2 inhibitor
    VTX-11e
    401
    CDK2 inhibitor, CDK9 inhibitor
    CYC065
    402
    CDK2 inhibitor, CDK9 inhibitor, PARP inhibitor
    olaparib + CYC065
    403
    MCL1 inhibitor, Bcl-xL inhibitor
    S63845 + A-1331852
    404
    PI3K inhibitor, Bcl-xL inhibitor, AKT inhibitor
    RG7440 + A-1331852
    405
    Topoisomerase II inhibitor, Selective estrogen receptor modulator, Selective estrogen receptor α inhibitor, PKCβ inhibitor
    doxorubicin hydrochloride + Z-endoxifen
    406
    ICAM-1-targeted CAR-T immunotherapy
    AIC100
    407
    MUC1-targeted CAR-T immunotherapy
    P-MUC1C-ALLO1
    408
    B7-H4-targeted antibody-drug conjugate, Microtubule inhibitor
    SGN-B7H4V
    409
    Retinoid X receptor agonist, HER2 inhibitor, HER4 inhibitor, EGFR inhibitor
    neratinib + IRX4204
    410
    Retinoid X receptor agonist, HER2 inhibitor
    tucatinib + IRX4204
    trastuzumab + IRX4204
    411
    Retinoid X receptor agonist
    IRX4204
    412
    CDK19 inhibitor, CDK4 inhibitor, CDK6 inhibitor, CDK8 inhibitor
    palbociclib + Senexin B
    palbociclib + SNX-631
    413
    CDK4 inhibitor, CDK6 inhibitor, Serine protease inhibitor, TMPRSS2 inhibitor
    palbociclib + nafamostat
    414
    Serine protease inhibitor, TMPRSS2 inhibitor
    nafamostat
    415
    Bcr-abl tyrosine kinase inhibitor, HER2-targeted antibody-drug conjugate, Src kinase inhibitor, c-KIT inhibitor, Microtubule inhibitor, PDGFR β antagonist, EphA2 receptor antagonist
    dasatinib + ado-trastuzumab emtansine
    416
    PI3K inhibitor, PARP inhibitor, FAK inhibitor, AKT inhibitor
    talazoparib + LY294002
    417
    β-catenin inhibitor, Microtubule stabilizer, Tubulin polymerization promoter, Alkylating agent, CBP inhibitor, Microtubule inhibitor
    docetaxel + cyclophosphamide + eribulin mesylate
    418
    CDK4 inhibitor, Sonic hedgehog inhibitor, Stem cell inhibitor, Apoptosis stimulant, CDK6 inhibitor
    palbociclib + GZ17-6.02
    419
    HDAC inhibitor, XPO1 inhibitor, MAPK inhibitor, HDAC10 inhibitor, HDAC1 inhibitor, PI3K inhibitor, HDAC2 inhibitor, AKT inhibitor, HDAC3 inhibitor
    selinexor + chidamide
    420
    Topoisomerase II inhibitor, DNMT inhibitor
    doxorubicin hydrochloride + decitabine
    421
    MCL1 inhibitor, BET inhibitor
    JQ-1 + S63845
    422
    ERK2 inhibitor, ERK1 inhibitor
    BVD-523
    423
    RSK inhibitor
    PMD-026
    424
    Immunostimulant, Free radical stimulant, Oxidative stress enhancer
    SM-88
    425
    PARP1 inhibitor, HER2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    fam-trastuzumab deruxtecan-nxki + AZD5305
    426
    HER2-targeted antibody-drug conjugate, Microtubule inhibitor, PARP inhibitor
    ado-trastuzumab emtansine + talazoparib
    427
    HER2 inhibitor, PARP inhibitor
    trastuzumab + talazoparib
    428
    Tubulin polymerization promoter, DNA synthesis inhibitor, Bcl2 inhibitor
    cisplatin + paclitaxel
    429
    HER2 inhibitor, WEE1 inhibitor
    trastuzumab + ZN-c3
    430
    Selective estrogen receptor degrader, WEE1 inhibitor
    ZN-c3 + ZN-c5
    431
    CDK4 inhibitor, CDK6 inhibitor, WEE1 inhibitor
    palbociclib + ZN-c3
    432
    YES1 inhibitor, Src kinase inhibitor
    NXP900
    433
    HER2-targeted antibody-drug conjugate, STING agonist
    XMT-2056
    434
    CYP51A1 inhibitor
    itraconazole
    435
    TGM2 inhibitor
    MD102
    436
    STAT3 inhibitor
    BP1003
    437
    PKC inhibitor
    AEB071
    438
    Bcr-abl tyrosine kinase inhibitor, HER2 inhibitor, HER4 inhibitor, EGFR inhibitor, Src kinase inhibitor, c-KIT inhibitor, PDGFR β antagonist, EphA2 receptor antagonist
    dasatinib + neratinib
    439
    mTOR inhibitor, HER2-targeted antibody-drug conjugate, Microtubule inhibitor
    everolimus + ado-trastuzumab emtansine
    MK-8776
    LY 2603618
    		440
    Chk1 inhibitor
    CHIR-124
    PD-407824
    PF-00477736
    441
    LATS kinase inhibitor
    VT02956
    442
    MCL1 inhibitor
    S63845
    443
    DOT1L inhibitor
    EPZ-5676
    444
    MYC inhibitor
    MYCi975
    445
    CDK9 degrader
    THAL-SNS-032
    446
    Androgen receptor inhibitor, ALK inhibitor
    enzalutamide capsule + ceritinib
    447
    USP8 inhibitor
    DC-U4106
    448
    Reactive oxygen species stimulant, Apoptosis stimulant, HSP70 stimulant
    STA-4783
    449
    Steroid receptor inhibitor, Estrogen receptor modulator
    SR16157
    450
    Src kinase inhibitor, FAK inhibitor
    AZD0530
    451
    PD-L1 inhibitor, DNA synthesis inhibitor, DNA cross linking agent
    PD-L1 inhibitor + oxaliplatin
    452
    HER2 degrader
    CH7C4
    453
    USP1 inhibitor, PARP inhibitor
    olaparib + RG6614
    454
    HER2-targeted antibody-drug conjugate, Microtubule inhibitor, CD47 inhibitor
    disitamab vedotin + ABBV-IMAB-TJC4
    455
    PD-L1 inhibitor, NK cell stimulant
    avelumab + CYNK-101
    456
    KU70/KU80 inhibitor, PARP1 inhibitor, MRN complex inhibitor
    VIO-01
    457
    Androgen receptor inhibitor, CDK7 inhibitor
    enzalutamide capsule + KRLS-017
    458
    ATR inhibitor, TROP-2-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    sacituzumab govitecan-hziy + BAY 1895344
    459
    CDK19 inhibitor, mTOR inhibitor, CDK8 inhibitor
    everolimus + SNX-631
    460
    PIK3CA inhibitor, pan-NOS inhibitor
    alpelisib + L-NMMA
    461
    PD-L1 inhibitor, HER2 inhibitor, PD1 inhibitor
    trastuzumab + BMS-202
    462
    ATR inhibitor, HER2-targeted antibody-drug conjugate, PARP inhibitor, Topoisomerase I inhibitor
    olaparib + fam-trastuzumab deruxtecan-nxki + BAY 1895344
    acalabrutinib
    		463
    BTK inhibitor
    zanubrutinib
    ibrutinib
    464
    KU70/KU80 inhibitor, PARP1 inhibitor, MRN complex inhibitor, PARP inhibitor
    olaparib + VIO-01
    465
    CXCR2 antagonist
    SB225002
    466
    Selective estrogen receptor activator, Cell death stimulant, Unfolded protein response activator
    TEQ103
    467
    β-tubulin inhibitor, α-tubulin inhibitor
    VERU-111
    468
    PRMT5 inhibitor
    GSK3326595
    469
    B7-H4-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    AZD8205
    470
    HER2 inhibitor, CD47 inhibitor, HER2 dimerization inhibitor
    pertuzumab + D3L-001
    471
    MUC1-targeted antibody-drug conjugate, HER3-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    DM002
    472
    γδ TCR modulator, EGFR inhibitor
    ACE2016
    473
    ATR inhibitor, HER3-targeted antibody-drug conjugate, Topoisomerase I inhibitor
    U3-1402 + BAY 1895344
    474
    DDX3 inhibitor, PARP inhibitor
    PARP inhibitor + RK-33
    No biomarker
    HER-2 positive
    HER-2 negative
    HER-2 amplification
    HER-2 underexpression
    HER-2 overexpression
    HER-2 mutation
    HER-2 expression
    HER-2 L755S
    HER-2 S310F
    HER-2 778insGSP
    HER-2 exon 19 deletion
    HER-2 exon 20 insertion
    HER-2 L755P
    HER-2 V777L
    HER-2 mutation + HER-2 T798I
    HER-2 A1170P
    HER-2 elevation
    HER-2 I655V
    HER-2 D769H
    HER-2 D769Y
    HER-2 R896C
    HER-2 V842I
    HER-2 L755_T759del
    HER-2 amplification + HER-2 L755S
    HER-2 amplification + HER-2 R157W
    HER-2 T862A + HER-2 L755S
    HER-2 K753E
    HER-2 L768S
    p95HER2 mutation
    HER-2 C634R
    HER-2 L869R
    HER-2 T798I
    HER-2 G309A
    HER-2 G778_P780dup
    HER-2 T798M
    HER-2 K676R
    HER-2 V773L
    HER-2 755_759del
    HER-2 Q680R
    HER-2 P780ins
    HER-2 R647K
    HER-2 R678Q
    HR positive
    HR negative
    ESR1 mutation + HR positive
    ER positive + PGR positive
    ESR1 wild-type + HR positive
    ER positive + PGR negative
    HR overexpression
    HR positive + ER overexpression
    HR positive + APOBEC signature
    ER positive + TP53 mutation
    ER positive
    ESR1 mutation
    ER positive + ESR1 mutation
    ER rs2234693
    ER mutation
    ER negative
    ER D538G
    ER Y537S
    ER E380Q
    ER Y537N + ER positive
    ER Y537S + ER positive
    ESR1 rs1801132
    ESR1 rs2228480
    ER positive + ESR1 mutation + TP53 mutation
    ESR1 rs2234693T>C
    ER D538G + ER positive
    ER F404L
    ER E380Q + ER positive
    ER L536Q
    ESR1 rs9322354
    ER Y537C
    ER Y537N
    ER overexpression
    ER amplification
    ER-L
    ER E380Q + ER F404L
    ER underexpression + ER Y537S
    ER underexpression
    ER T594T
    ER D538G + ER F404L
    PIK3CA mutation
    PIK3CA E542K
    PIK3CA Q75E
    PIK3CA E545
    PIK3CA N345K
    PIK3CA N345K + PIK3CA N1044K
    PIK3CA K111N
    PIK3CA G106_108del
    PIK3CA Q546
    PIK3CA G1049R
    PIK3CA H1047X
    PIK3CA E545X
    PIK3CA R38C
    PIK3CA H1047
    PIK3CA M1043I
    PIK3CA H1047R
    PIK3CA E545K
    PIK3CA amplification
    PIK3CA wild-type
    PIK3CA E542Q
    PIK3CA E453K
    PIK3CA H1047L
    PIK3CA mutation + HR negative
    PIK3CA mutation + MSI-L/dMMR
    PIK3CA I391M
    PIK3CA C420R
    PIK3CA exon 20 mutation + HR positive
    PIK3CA exon 9 mutation + HR positive
    PIK3CA exon 7 mutation + HR positive
    PIK3CA mutation + HR positive
    PIK3CA E542K + HR positive
    HR positive + PIK3CA exon 10 mutation
    HR-positive + PIK3CA wild-type
    HR positive + PIK3CA H1047R + PIK3CA D350G + ER D538G
    ESR1 mutation + PIK3CA mutation + HR positive
    PIK3CA amplification + PIK3CA mutation + HR positive
    HR positive + PIK3CA H1047R + ER D538G
    HR positive + PIK3CA H1047R
    BRCA2 mutation
    BRCA2 overexpression
    BRCA2 5396insC
    BRCA2 N255fs + D252fs
    PD-L1 expression
    PD-L1 underexpression
    PD-L1 overexpression
    TMB-H + PD-L1 expression
    PD-L1 negative
    PD-L1 amplification
    MSI-H/dMMR + PD-L1 expression
    PD-L1 elevation
    BRCA2 mutation + HR positive
    HR negative + BRCA2 mutation
    HR positive + BRCA2 mutation
    BRCA2 mutation + ER positive + PGR positive
    BRCA1 mutation + HR positive
    HR negative + BRCA1 mutation
    HR positive + BRCA1 mutation
    HR positive + HER-2 negative
    ER positive + PGR negative + HER-2 negative
    HR positive + HER-2 positive
    HER-2 amplification + ER positive + PGR negative
    HR positive + HER-2 amplification
    HR positive + HER-2 mutation
    HR positive + HER-2 underexpression
    HR negative + PD-L1 expression
    PIK3CA mutation + HR positive + HER-2 negative
    BRCA1 mutation
    BRCA1 promoter methylation
    BRCA1 E1446*
    HR positive + PD-L1 expression
    BRCA1 307 T> A (L63*)
    ER negative + HER-2 positive + PGR positive + PIK3CA mutation
    BRCA1 2080delA
    BRCA1 R1443*
    BRCA1 2080delA + CCNE1 overexpression
    BRCA1 3363delGAAA
    BRCA1 5396insC
    BRCA1 deletion
    BRCA1 L1780P
    ERBB3 overexpression
    ERBB3 expression
    ERBB3 positive
    ERBB3 G284R
    ERBB3 mutation
    ERBB3 E952Q
    PTEN deletion
    PTEN mutation
    PTEN K237fs
    PTEN-L
    PTEN Hypermethylation
    PTEN V85
    PTEN underexpression
    PTEN expression
    PTEN rs701848
    BRCA wild-type
    PIK3CA mutation + ER positive
    PIK3CA mutation + ER negative
    BRCA1 mutation + BRCA2 mutation
    ER positive + ESR1 mutation + PIK3CA mutation
    PIK3CA mutation + ER mutation
    PIK3CA mutation + ESR1 mutation
    ER negative + PIK3CA H1047R
    ER positive + PIK3CA H1047R
    PIK3CA mutation + ESR1 wild-type
    PIK3CA wild-type+ ESR1 wild-type
    PIK3CA H1047R + PIK3CA D959N + ER E380Q
    FCGR3A 158V
    FCGR3A 158F
    HRD
    FGFR1 amplification
    AKT1 mutation
    EGFR expression
    FGFR2 amplification
    EGFR mutation
    FGFR2 overexpression
    FGFR2 Y375C
    AKT1 E17K
    FGFR2 fusion
    AKT1 amplification
    EGFR amplification
    FGFR1 overexpression
    FGFR1 expression
    EGFR overexpression
    AKT1 overexpression
    FGFR2 mutation
    FGFR1 mutation
    EGFR positive
    AR positive
    HER-2 underexpression + ER underexpression
    TMB-H
    TMB-L
    TP53 R209fs*
    TP53 mutation
    ABCB1 C3435T
    TP53 wild-type
    AR overexpression
    ABCB1 C1236T
    ER positive + HER-2 D769H + HER-2 V777L
    ABCB1 G1236T + ABCB1 G2677T
    TP53 D281E
    ABCB1 G2677T
    ER positive + HER-2 negative
    TP53 expression
    AR underexpression
    AR negative
    AR expression
    TP53 R273H
    ER negative + HER-2 negative
    TP53 R175H
    RAB5A expression
    INPP4b deletion
    MDM2 mutation
    PD-1 overexpression
    ATM mutation
    HSD17B2 overexpression
    FRS2 mutation
    HIF1A overexpression
    CDKN2A mutation
    BACH1 overexpression
    BRCA1 mutation + HER-2 negative
    BRCA2 mutation + HER-2 negative
    ACTA2 elevation
    miR-21 overexpression
    IGFBP7 overexpression
    NES expression
    AR positive + ER positive
    MYBL2 overexpression
    ADRB2 overexpression
    PD-L1 overexpression + ER positive
    BRCA mutation
    CDKN2B mutation
    PRKCA mutation
    FGFR1 overexpression + HR positive
    BRAF V600E
    FGFR1 amplification + HR positive
    PGR positive
    PGR expression
    CD8 positive
    RB1 mutation + HR positive
    PGR overexpression
    RB1 mutation
    KDR overexpression
    BRAF G469E
    CD8-H
    RB1 expression
    KDR V297I
    KDR rs1870377
    CD8 overexpression
    RB1 deletion
    RB1 overexpression
    BRAF T1799A
    CDKN2A deletion
    MDM2 amplification
    RB1 negative
    CDKN2A overexpression
    PGR negative
    BRAF mutation
    ACTA2 overexpression
    NTRK1 fusion
    MSI-H/dMMR
    AKT1 E17K + HR positive
    TOP2A amplification
    EZH2 A490T
    CDK12 amplification
    TOP2A deletion
    FGFR3 overexpression
    NRG1 fusion
    NF2 K159fs*16
    NF2 mutation
    CCR5 expression
    AKT1 mutation + ER negative
    AKT1 mutation + ER positive
    CXCR4 positive
    ER positive + ESR1 mutation + CCND1 amplification
    ER positive + ESR1 mutation + FGFR1 amplification
    RET fusion
    BARD1 T351T
    CCR5 positive
    YAP1 underexpression
    ER positive + FGFR1 amplification
    ER L536H + ER D538G + CCND1 amplification
    AKT1 mutation + HR positive
    PARD3 expression
    BARD1 mutation
    CDK12 mutation
    AXL-L
    YAP1 overexpression
    CXCR4 expression
    NRG1 overexpression
    HR positive + ERBB3 underexpression
    AXL expression
    HR positive + ERBB3 overexpression
    FGFR3 mutation
    RET overexpression
    EZH2 rs2302427C>G
    VEGFA overexpression
    PARD3 overexpression
    VEGFA rs833061
    CXCR4 overexpression
    EZH2 rs201135441C>T
    NF2 negative
    WSB2 expression
    EGF overexpression
    PD-L2 overexpression
    CTLA4 overexpression
    RAD51 underexpression
    CHEK2 mutation
    SLCO1B1 rs2306283
    TA-MUC1 elevation + EGFR expression
    IRS1-L
    IGFBP5-L
    ASXL1 mutation
    HRD + BRCA wild-type
    TMEM45B overexpression
    RRM2 overexpression
    BAG1 overexpression
    GRB7 overexpression
    PTEN deletion + BRCA1 mutation
    CD38 expression
    PSIP1 expression
    ACSL4 overexpression
    GPX4 overexpression
    CCNE1 mutation
    ANXA6 underexpression
    COL4A5 mutation
    COL22A1 mutation
    LLGL2 underexpression + SLC7A5 underexpression
    SLC7A5 underexpression
    LLGL2 underexpression
    PCDHA1 mutation
    SDK2 mutation
    L1CAM mutation
    KPRP mutation
    CXCL12-L
    CFAP58 mutation
    CACNA1S mutation
    ARID1A mutation
    TMB-H + HER-2 positive
    MMP11 overexpression
    PTEN deletion + ER positive
    KRAS mutation
    CCNA2 overexpression
    FOXP3 overexpression
    CD4 overexpression
    FCRL1 overexpression
    KDM1A expression
    IRF8 overexpression + ER negative
    KMT2B mutation
    KIR3DL2 mutation
    MUC16 mutation
    TUBB3 deletion
    RRM1 deletion
    LRRC3B hypomethylation
    High HDAC6 score + HR positive
    IL6 elevation
    TNFA elevation
    IL18 elevation
    CCNE2 overexpression + PIK3CA mutation + ER positive
    TFF3 overexpression + ER positive
    TFF1 overexpression + ER positive
    MYC mutation + ER positive
    BRCA2 mutation + ER positive
    miR-142 overexpression
    MCM10 overexpression
    VHL mutation
    RBPMS expression
    UNC13D mutation
    SLBP expression
    miR-621 overexpression
    ADAMTS3 mutation
    WNT7A mutation
    BPIFB2 mutation
    MSI2 overexpression
    FOXA1 expression + ER positive
    CAV1 overexpression + CAV2 overexpression
    KLF4 overexpression
    PRMT5 overexpression
    FSIP1 overexpression
    MYC expression
    BLM mutation
    NOTCH3 expression
    NOTCH3 expression + ER positive + PGR positive
    CCND1 mutation + HR positive
    CDKN1B mutation + HR positive
    CDK4 mutation + HR positive
    CCND2 mutation + HR positive
    FRS2 amplification + MDM2 amplification
    HR positive + TNFRSF11A overexpression
    MAF1 overexpression
    miR-221 underexpression
    miR-125b-2 underexpression
    RAD51 overexpression + HR positive
    MUC1 elevation
    WBP2 overexpression
    CCNB2 expression
    HR positive + AR positive
    CCDC69 overexpression
    IGHG1 overexpression
    DNMT3A mutation
    AKT2 expression
    FGFR4 overexpression
    SIRT3 expression
    ATR mutation
    MSH6 mutation
    KIM1 overexpression
    EMSY mutation
    PARP10 mutation
    PPM1D mutation
    ATRX mutation
    FGF3 amplification
    FGF amplification
    FANCA mutation
    PALB2 mutation
    ZNF689 underexpression
    RAD21 mutation
    CDX-2 expression
    HER-2 amplification + EGFR-ZNF880 fusion + EGFR E114K
    TGFBI promoter hypermethylation
    PD-L1 expression + CD68 positive
    MMP17 expression + EGFR expression + RB1 expression
    BRCA1 mutation + HER-2 negative + ER positive + PGR positive
    STK11 F354L
    ETV6-NTRK3 fusion
    EML4-ALK fusion
    FOXD1 expression
    PIK3CA H1047R + PIK3C2B amplification
    CCNE1 overexpression + PIK3CA muattion + ER positive
    HR positive + BRCA positive
    POLE E790Q + ERBB2 amplification + TMB-H
    PTEN mutation + STK11 mutation
    AKT1 mutation + mTOR mutation
    SEMA7A expression
    ATM expression + ATM T2333fs* + EGFR negative
    PIK3CA H1047R + HER-2 amplification
    MTOR mutation + HR positive
    BRCA1 mutation + RAD51B deletion
    ALK fusion
    HR positive + TMB-L
    MSI-H/dMMR + TMB-H
    PIK3R1 EY451delinsD
    POLE mutation + PD-L1 negative + TMB-H
    BAP1 R300Gfs*6 + PD-L1 expression
    BAP1 deletion + TMB-L + PD-L1 expression
    STRN-ALK fusion
    SLC3A2-NRG1 fusion
    ETV6-NTRK3 fusion + CRTC3-NTRK3 fusion
    HR positive + BRAF V600E
    CCDC6-RET fusion
    ER positive + MLH1 1835del3 + MSI-H/dMMR + TMB-H
    TK1 elevation
    NOS2 underexpression
    ER positive + FGFR3 amplification
    LMNA-NTRK1 fusion
    CD47 overexpression
    MLL2 mutation
    FGF4 amplification + ER positive
    PTCH1 mutation
    NEFH mutation
    USH2A mutation
    TYMS overexpression + HR positive
    FGF3 amplification + ER positive
    EGFR mutation + ER positive
    FGF19 amplification + ER positive
    TLE3 expression
    HMGB1 positive
    BIN3 expression
    CTDSP1 expression
    FTO expression
    EPRS1 expression
    GPNMB overexpression
    GATA3 mutation
    APOBEC3B deletion
    RAD51D mutation
    SORT1 expression
    FANCL mutation
    PPP2R2A mutation
    RAD51B mutation
    RAD51C mutation
    RAD54L mutation
    BRIP1 mutation
    CHEK1 mutation
    BCL2 positive
    NTRK2 fusion
    NTRK3 fusion
    PTEN mutation + HR positive
    SEMA7A overexpression
    MUC1 expression
    CCNE1 expression
    MYC amplification
    miR-125b-2 expression
    ARID1A deletion
    CCNE1 overexpression
    HR positive + TMB-H
    CCNE1 amplification
    MYC overexpression
    MYC mutation
    RAD21 amplification
    PIK3R1 mutation
    CD47 positive
    SORT1 positive
    FGF3 mutation
    HR positive + CCND1 amplification
    MYC underexpression
    HER-2 V777L + PIK3CA H1047R
    PIK3CA mutation + HER-2 amplification
    HMGB1 underexpression
    miR-221 expression
    HR positive + PTEN deletion
    High ALC
    Low NLR
    DDR
    TROP2 overexpression
    Rbsig overexpression
    AR-regulated gene expression pathway signature
    DDR signature score
    Low PLR
    TOP1 deletion
    14-gene IGG signature overexpression
    GeparSixto immune signature
    6-gene WNT pathway signature
    76-gene signature
    MAF1 expression
    MHC-II expression
    Choline elevation
    CDYL2 overexpression
    KLF8 overexpression
    FOXA1 mutation
    BRCA1 mutation + TP53 mutation
    NF1 deletion
    HR negative + EGFR amplification
    CCDC170 overexpression
    AFAP1-AS1 overexpression
    PPP2R2B underexpression
    PPP3CA expression
    PIK3CA mutation + PTEN mutation
    HPGD underexpression
    ADAM9 overexpression
    PTPN12 deletion
    NOTCH2 mutation
    FOXA1 overexpression
    ANXA1 overexpression
    CCL2 elevation
    LIFR expression
    CACNA1D E953D
    HDAC5 deletion
    IGF1R amplification
    TENM4-NRG1 fusion
    BOP1 overexpression
    CCND1 overexpression
    ABCC4 overexpression
    CD276 overexpression
    CDK2 overexpression
    CEACAM6 positive + HER-2 positive
    MIA underexpression
    KRT5 underexpression
    CDH3 underexpression
    KRT17 underexpression
    SFRP1 underexpression
    CXXC5 overexpression
    GPR160 overexpression
    MLPH overexpression
    CASP9 mutation
    KRT14 underexpression
    ABCC2 overexpression
    miR-503-5p overexpression
    ABCB4 overexpression
    TET2 deletion + DNMT3A mutation
    miR-34a expression
    ABCG2 overexpression
    TUSC7 overexpression
    NSD3 overexpression
    CCND1 amplification
    SPP1 elevation
    SPP1 mutation
    miR-210 overexpression
    TLS gene signature
    CD36 overexpression
    lncRNA DILA1 overexpression
    RET fusion + TP53 mutation
    miR-1246 overexpression
    CHID1 overexpression
    AGR3 expression
    ICAM1 overexpression
    EPCAM positive + CD44 positive + CD24 negative
    VTCN1 underexpression
    EPCAM positive + CD44 positive + CD24-L
    IGF1 rs2016347
    KRAS mutation + CDK9 overexpression + HR positive
    ERBB4 H809G + ER positive
    SMARCB1 mutation
    ANXA1 expression
    ZNF649-AS1 overexpression
    High MLR
    High NLR
    LDH elevation
    SH3BGRL overexpression
    RBM38 overexpression
    NF1 mutation
    AKR1C3 overexpression
    AKR1C2 overexpression
    AKR1C1 overexpression
    YES1 amplification
    SEMA6D underexpression
    SLC9A2 overexpression
    EPCAM expression
    ERBB4 expression
    CDH1 deletion
    CDH1 mutation
    MDM4 mutation
    FBXW7 underexpression
    NPY1R underexpression
    CCAT2 overexpression
    DLGAP1-AS1 overexpression
    DDX11-AS1 overexpression
    USP18 overexpression
    SPRED2 deletion
    miR-101-5p overexpression
    PIK3CA mutation + PTEN underexpression
    MMP1 hypomethylation
    MMP1 overexpression
    HR positive + CCNE1 overexpression
    TROP2 expression
    HR positive + PLK1 overexpression
    SOX9 expression
    CD73 elevation
    BIRC5 overexpression
    CTSD positive + ER positive
    High PLR
    AGR2 overexpression
    HGF amplification
    ADRM1 overexpression
    MET amplification
    PTPN2 amplification
    STAT6 deletion + HER-2 overexpression
    HDC overexpression + HR positive
    TNFRSF1A overexpression + HR positive
    miR-155 expression
    TGM2 overexpression
    BCL6 overexpression
    IL21R overexpression
    LIG1 deletion
    STAT3 expression
    HR positive + TP53 mutation
    PRO-C3 elevation
    PC3X elevation
    TP53 wild-type + ER positive
    GJA1 expression
    CD24 expression
    NCOR2 overexpression
    ERCC1 negative
    ERCC1 overexpression
    XRCC1 overexpression
    CDKN2C mutation
    ER positive + CDK6 overexpression
    BCL11B mutation
    FER overexpression
    LZTS1 overexpression
    MCL1 overexpression + HER-2 amplification
    HR positive + BRCA2 mutation + PALB2 mutation
    ALDH1A1 positive
    CHD4 mutation
    HR positive + BRCA1 mutation + PALB2 mutation
    35-gene signature
    MLH1 mutation
    HER-2 amplification + AXL expression
    SMO mutation
    MUC4 expression
    SPARC overexpression
    THBS1 overexpression
    SOX9 overexpression
    KIF11 overexpression
    RUNX3 underexpression
    miR-638 overexpression
    HLA-E mutation
    MCL1 amplification
    HNRNPD overexpression
    H3F3C mutation
    FGF23 mutation
    SNHG16 mutation
    MPZL3 overexpression
    CDK4 overexpression
    CYP2D6 deletion
    GNAS mutation
    BCL2L1 mutation
    LAG3 mutation
    CCND2 mutation
    LINC00667 overexpression
    SESN1 mutation
    RFC3 overexpression + ER positive
    MLH3 overexpression + HR positive
    TROP2 positive
    PCNA overexpression + HR positive
    CETN2 overexpression + MLH3 overexpression + PCNA overexpression + HR positive
    CETN2 overexpression + HR positive
    TNFRSF1B overexpression
    GSTP1 overexpression
    IL6R overexpression
    TCEAL9 overexpression
    SAMHD1 expression
    IL10 overexpression
    DLD overexpression
    LCN2 overexpression
    SAA2 overexpression
    SAA1 overexpression
    KLK7 overexpression
    IL19 overexpression
    ACAT1 overexpression
    NDUFA4L2 overexpression
    PLK1 overexpression
    MIR497HG deletion
    ANIB1 overexpression
    NOTCH4 expression
    NOTCH1 expression + NOTCH4 expression
    NOTCH1 expression
    CCL20 overexpression
    HR positive + MYC mutation
    HR positive + MYC amplification
    HR positive + RB1 mutation
    APBB1 expression
    NODAL overexpression
    SALL4 overexpression
    TRIM3 overexpression
    BRCA wild-type + TP53 mutation
    AGR2 elevation
    SOX2 overexpression
    KMT2D mutation
    MELTF overexpression
    ERBB3 expression + MUC1 expression
    PTPRT overexpression
    PTK7 expression + TROP2 expression
    RAD50 deletion
    TSC2 C1450G
    BRCA2 mutation + RB1 deletion
    BRCA1 mutation + RB1 deletion
    TP53 R280K + BRCA wild-type
    TNC overexpression
    DCN overexpression
    CPA3 overexpression
    HNRNPAB overexpression
    SLC39A6 overexpression
    EGFR overexpression + KRAS 13D
    MAPT overexpression
    MERTK expression
    GSTP1 rs1138272
    TMEM225B rs10273424
    NECTIN4 overexpression
    IGF1R overexpression
    GSPT1 deletion
    miR-98-5p underexpression
    PRLR underexpression
    LAMP1 expression
    GH1 overexpression
    SLC39A6 expression
    VTCN1 expression
    ROR1 expression
    TXNIP underexpression
    TPBG overexpression
    LAMTOR5 overexpression
    MTOR A2034V
    CDK6 overexpression
    KRAS mutation + HR positive
    RSF1 amplification
    MYC amplification + HER-2 amplification
    NCAPG overexpression
    AURKA overexpression
    GSK3B overexpression
    APC mutation
    CSMD1 overexpression
    DUSP6 expression
    EIF4EBP1 overexpression
    ZNF268 overexpression
    AKT3 expression
    miR-186 overexpression
    SMARCA4 mutation
    PKD1 mutation
    HR positive + BRIP1 amplification
    MALAT1 overexpression
    PIK3CA mutation + PTEN deletion
    HER-2 amplification + PTEN deletion
    MTOR M2327I
    MTOR F2108L
    HR positive + AURKA mutation
    ER-CCDC170 fusion
    RBBP8 E281
    CUL7 overexpression
    NOTCH1 mutation
    PARP1 overexpression
    DEDD overexpression
    PSMD4 amplification
    TIMP1 overexpression
    SF3B1 K700E
    SF3B1 K666Q
    SF3B1 K666E
    TIAM1 overexpression
    CD276 expression
    STAT6 underexpression
    FGFR mutation
    HAVCR2 deletion
    ST14 expression
    miR-155 overexpression
    FERMT1 expression
    MFI2 expression
    PAK4 deletion
    HR positive + AURKA amplification
    PTK7 expression
    CASP8 overexpression
    CASP9 underexpression
    GFRA1 overexpression
    CREBBP deletion
    CREBBP mutation
    FOXC1 expression
    HR positive + RAD51C amplification
    PAX2 promoter methylation
    SORL1 deletion
    miR-381 underexpression
    CCND1-H
    MAP3K6 overexpression
    GNRHR expression
    NQO1 positive
    ABCC5 expression
    HASPIN expression
    MAP3K1 mutation
    IGF2 overexpression
    SETDB1 overexpression